SkinHealth Systems Inc. SKIN
Medical/Dental Instruments · IPO 2020 · data as of November 13, 2026
SkinHealth Systems Inc. (SKIN) is a healthcare company listed in the US with a market value of about $107M. In the twelve months to September 30, 2026 it had revenue of $289M and net income of -$18M, a net margin of -6.3%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (1/5).
Key numbers: a P/E of 9.3, a price to free cash flow of 4.7, 5-year revenue growth of 20% a year, a 5-year average ROIC of -8%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 11% below the current price.
About SkinHealth Systems
SkinHealth Systems is listed in the US and classified in medical/dental instruments, IPO year 2020. Revenue went from $167M in 2019 to $301M in 2025, growth of about 10.3% a year. It was profitable in 1 of the last 7 years in our data. Its share count fell by 9% over three years (buybacks). It spends 2% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- 5-year revenue growth above 8% a year
- Positive free cash flow
- Share count down over 3 years (buybacks)
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $289M | $301M | $334M | $398M | $366M | $260M | $119M | $167M |
| Net income | -$18M | -$10M | -$29M | -$100M | $44M | -$379M | -$29M | -$2M |
| Free cash flow | $23M | $37M | $15M | $18M | -$117M | -$40M | -$16M | -$7M |
| EPS (diluted) | $1.75 | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.71 | $-0.85 | $-0.05 |
| Net margin | -6.3% | -3.2% | -8.7% | -25.2% | 12.1% | -145.6% | -24.5% | -1.0% |
| ROIC | — | -5.2% | -10.8% | -15.8% | -2.7% | -3.8% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is SkinHealth Systems’s P/E ratio?
About 9.3, based on the last twelve months of diluted earnings per share.
Is SkinHealth Systems stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 11% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SkinHealth Systems pay a dividend?
Not currently.
Is SkinHealth Systems a good stock to buy?
We do not give buy or sell advice. SkinHealth Systems scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.